Warfarin Sensitivity/Resistance SNPs

Description
Analysis of SNPs in the VKORC1, CYP2C9 & CYP4F2 genes associated with Warfarin resistance or sensitivity.
Clinical details
Some patients show an apparent resistance or sensitivity to Warfarin when started on standard dosing regimes. Individuals with the CYP2C9*2 and CYP2C9*3 genotype show impaired metabolism of warfarin and, therefore, require a lower dose compared to CYP2C9*1 individuals. The T allele for the VKCORC1 1173C>T polymorphism is associated with a lower dose requirement. Individuals homozygous (T/T) for the CYP4F2 450C>T polymorphism show a mild resistance, requiring approximately 1mg/day extra warfarin compared to C/C individuals.
Related condition
Reference range

n/a

Units
n/a
Synonyms
VKORC1 CYP2C9 CYP4F2 Warfarin resistance Warfarin sensitivity
Testing site
Synnovis : Genomics : St Thomas' Hospital
Laboratory
Molecular Haemostasis
Sample type and volume required
1 x Edta
Call in advance
no
Storage and transport
transport at ambient temperature
Turnaround time
14 days
Contacts

Molecular Haemostasis Laboratory at St Thomas’ Hospital
Phone: 020 7188 2798
Haemostasis and Thrombosis
North Wing – 4th floor
St Thomas’ Hospital
Westminster Bridge Road
London SE1 7EH
Laboratory opening times
Monday – Friday 09.00 – 17.00

Last updated:

Back to search